People news

Share this article:
Merz USA named Jack Britts president and CEO. Britts joins from Sepracor, where he was most recently group VP in charge of commercial operations, responsible for the commercialization of Lunesta. He replaces Terry Conrad, who has left the company. 
Dorland Global named Cheryl Makopoulos as its VP, management supervisor. Makopoulos joins the agency from GlaxoSmithKline, where she was senior product manager for Boostrix. She will be responsible for managing three key accounts and working on new business acquisition efforts. 
National Institutes of Health director Dr. Elias Zerhouni is stepping down from the post in October. Zerhouni's more than six-year tenure at NIH was marked by a long congressional investigation into conflicts of interest among agency scientists, resulting in a ban on consulting deals between NIH scientists and pharma or device companies, and his development of the NIH Roadmap for Clinical Research. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media